TRDA (STOCKS)
Entrada Therapeutics, Inc. Common Stock
$11.070000
+0.250000 (+2.31%)
Prev close: $10.820000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Dipal Doshi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $431.87M
- Employees
- 183
- P/E (TTM)
- -4.32
- P/B (TTM)
- 1.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.06 | $-0.96 | -0.1012 | -10.55% |
|
Jun 2025 (Q2)
|
$-1.04 | $-0.86 | -0.1755 | -20.30% |
|
Mar 2025 (Q1)
|
$-0.42 | $-0.80 | +0.3848 | +47.81% |
|
Dec 2024 (Q4)
|
$0.03 | $-0.68 | +0.7132 | +104.39% |